
24.34BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US5049221055
CUSIP
50540R102
Sector
Healthcare
Industry
Diagnostics & Research
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
27.18
PEG Ratio
1.30
Book Value
106.06
Dividend Share
2.88
Dividend Yield
0.92%
Earnings Share
11.3
Wall Street Target Price
312.35
EPS Estimate Current Year
18.01
EPS Estimate Next Year
19.41
EPS Estimate Current Quarter
4.1159
EPS Estimate Next Quarter
4.7681
Most Recent Quarter
-
Revenue TTM
14,144,199,680
Gross Profit TTM
4,078,299,904
EBITDA
2,252,999,936
Profit Margin
6.66%
Return On Assets TTM
5.31%
Return On Equity TTM
11.05%
Revenue Per Share TTM
170.669
Qtly Revenue Growth YOY
5.80%
Diluted Eps TTM
11.3
Qtly Earnings Growth YOY
32.90%
Trailing PE
27.18
Forward PE
17
Price Sales TTM
1.8122
Price Book MRQ
2.8855
Enterprise Value Revenue
2
Enterprise Value EBITDA
15
71.01
1.62%687.76
-2.46%235.02
-1.45%266.51
-1.15%377.31
-0.98%574.26
-0.34%194.98
-0.33%556.62
-0.30%138.37
-0.18%21.55
-0.05%